RE:RE:RE:Interesting Chart Pattern Shows.......What surprises me as well are those involved directly in the research, those that work at Ceapro, I don't know if they are actively buying or recommending this company to their social circle for investment consideration. You know what Peter Lynch had said about looking for investment ideas.
prophetoffacts wrote: "A muted response from the market so far, that is another sign of in-efficient markets in the nano-cap stock universe. One requisite of efficient markets is dissemination of information and investors reacting accordingly. Absent here for sure."
MBX.to climbed as much as 18% the next day after I posted about it here as an example of inefficiency in small caps.
The timing of the government funding for mass-scale commercial production CZO received is interesting given pre-clinical results were expected to be completed by now and were confirmatory in nature. I just don't think a world-changing drug is expected from yeast beta glucan or off-the-radar CZO. The presentation of the preclinical results, discussion of mechanism by Dr. Kjetil Ask, filing and acceptance of clinical trials and the potential hiring of Dr. Jean-Claude Tardif for human trials would be a game-changer in getting the message out.